HomeTYP • ASX
add
Tryptamine Therapeutics Ltd
Previous close
$0.045
Day range
$0.043 - $0.045
Year range
$0.017 - $0.057
Market cap
47.47M AUD
Avg Volume
6.10M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Feb 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 745.86K | -41.07% |
Net income | -988.18K | 23.20% |
Net profit margin | — | — |
Earnings per share | -0.01 | 0.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Feb 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 420.81K | 859.80% |
Total assets | 703.97K | 40.49% |
Total liabilities | 6.56M | 230.26% |
Total equity | -5.86M | — |
Shares outstanding | 96.42M | — |
Price to book | -0.75 | — |
Return on assets | -122.01% | — |
Return on capital | 859.21% | — |
Cash Flow
Net change in cash
| (CAD) | Feb 2024info | Y/Y change |
|---|---|---|
Net income | -988.18K | 23.20% |
Cash from operations | -1.66M | -110.13% |
Cash from investing | — | — |
Cash from financing | 22.21K | — |
Net change in cash | -1.64M | -107.44% |
Free cash flow | -1.34M | -354.19% |
About
Founded
2019
Website
